Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s10067-017-3570-4
Published Online: 2017-02-11
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boman, Antonia
Kokkonen, Heidi
Ärlestig, Lisbeth
Berglin, Ewa
Rantapää-Dahlqvist, Solbritt
License valid from 2017-02-11